IR情報

2024/08/16~2025/01/15

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2025
01/151,6881,6921,6261,641-3.7%266,400683億1876万+0.92%
01/1415:30 ESG 投資指数「FTSE Blossom Japan Sector Relative Index」の構成銘柄に継続選定されました
01/141,6601,7141,6601,704+2.1%321,700709億4160万+5.06%
01/101,6501,6741,6371,669+1.09%119,000694億8447万+3.15%
01/091,6891,6921,6441,651-1.67%151,800687億3509万+2.17%
01/081,6711,6931,6571,679+1.21%203,400699億79万+4.03%
01/071,6401,6721,6231,659+2.92%253,700690億6815万+3.11%
01/061,6841,6841,6041,612-3.36%251,800671億1142万+0.5%
01/068:30 2025年(令和7年)元旦 新年の挨拶
2024
12/301,6961,6961,6581,668-1.65%219,200694億4284万+4.12%
12/271,7041,7091,6861,696+0.53%187,600706億855万+6.27%
12/261,6771,6981,6681,687+0.6%190,800702億3385万+6.23%
12/251,7201,7301,6641,677-2.73%311,700698億1753万+6.07%
12/241,6801,7251,6731,724+2.74%468,000717億7425万+9.67%
12/231,6501,7101,6481,678+4.61%740,200698億5916万+7.56%
12/201,6501,6861,5961,604+4.43%918,200667億7836万+3.48%
12/191,5351,5431,5251,536-1.29%134,600639億4736万-0.45%
12/181,5381,5801,5381,556+1.17%162,000647億8001万+0.97%
12/171,5531,5531,5121,538-1.91%266,000640億3063万+0.07%
12/161,5851,5931,5671,568-0.82%121,300652億7960万+2.15%
12/131,5791,5931,5671,581-0.75%178,400658億2082万+3.2%
12/121,5951,6041,5751,593-0.06%233,800663億2041万+4.39%
12/111,5911,6081,5731,594+0.95%211,700663億6204万+4.8%
12/101,5941,5941,5671,579-0.94%233,600657億3755万+4.5%
12/091,5951,6081,5821,594+0.82%247,100663億6204万+6.48%
12/061,5901,5991,5641,581+0.51%195,600658億2082万+6.68%
12/051,5511,5841,5401,573+1.55%215,400654億8776万+7.08%
12/041,6001,6001,5151,549-3.19%366,200644億8858万+6.39%
12/031,6051,6151,5931,600-1.05%273,800666億1184万+10.8%
12/021,5931,6251,5821,617+1.25%482,200673億1959万+13.16%
11/291,5501,6021,5421,597+2.77%518,600664億8694万+13.02%
11/281,5601,5641,5411,554-0.06%278,500646億9674万+11.08%
11/271,5431,5601,5271,555+0.06%283,500647億3838万+12.11%
11/261,5251,5591,5151,554+2.3%442,600646億9674万+13.02%
11/268:30 Satsuma社の経鼻偏頭痛薬STS101の米国FDAによる新薬承認再申請受理について
11/251,5251,5421,5151,519+1.47%354,700632億3961万+11.36%
11/221,5401,5471,4661,497-0.33%436,000623億2370万+10.48%
11/211,4641,5091,4461,502+3.59%463,800625億3186万+11.59%
11/201,4581,4721,4411,450+1.54%307,400603億6698万+8.61%
11/191,4241,4451,4121,428+0.56%241,900594億5106万+7.69%
11/181,4221,4451,4141,420-1.46%227,800591億1800万+7.82%
11/151,4791,4821,4381,441-2.31%307,300599億9228万+10%
11/141,4771,4891,4581,475-0.2%339,400614億779万+13.29%
11/131,4701,4891,4641,4780%348,100615億3268万+14.31%
11/121,4901,5001,4751,478-0.81%371,300615億3268万+15.02%
11/111,4441,5001,4441,490+4.63%615,700620億3227万+16.86%
11/081,4581,4581,4181,424-3.13%663,000592億8453万+12.48%
11/071,3831,4761,3821,470+9.05%1,276,100611億9962万+16.85%
11/0611:30 2025年3月期上期決算説明資料
11/0611:30 2025年3月期第2四半期決算短信〔日本基準〕(連結)
11/0611:30 2025年3月期第2四半期連結業績予想と実績との差異に関するお知らせ
11/0611:30 剰余金の配当(中間配当)に関するお知らせ
11/061,2591,3781,2531,348+8.62%920,400561億2047万+8.01%
11/051,2201,2501,2121,241+1.64%211,700516億6580万+0.08%
11/011,2301,2481,2201,221-1.69%184,400508億3316万-1.45%
10/311,2601,2771,2381,242-0.08%176,900517億744万+0.24%
10/318:30 Satsuma社の経鼻偏頭痛薬STS101の新薬承認再申請実施のお知らせ
10/301,2511,2661,2341,243-0.24%421,800517億4907万+0.4%
10/291,2501,2521,2371,246+0.97%95,200518億7397万+0.73%
10/281,2121,2361,2111,234+1.56%105,200513億7438万-0.16%
10/251,2421,2481,2111,215-2.17%131,200505億8336万-1.54%
10/241,2431,2491,2251,242-0.72%99,800517億744万+0.81%
10/231,2751,2781,2431,251-1.5%177,000520億8213万+1.87%
10/221,2761,2771,2611,270-1.17%141,900528億7314万+3.76%
10/211,2841,2931,2711,285+0.55%200,200534億9763万+5.33%
10/181,2701,2791,2541,278+0.63%196,400532億620万+5.27%
10/171,2511,2731,2511,270+2.83%243,900528億7314万+5.13%
10/161,2201,2431,2101,235+1.06%149,700514億1601万+2.66%
10/151,2201,2341,2101,222+1.33%125,800508億7479万+1.83%
10/111,2421,2431,2061,206-2.98%155,100502億867万+0.67%
10/101,2591,2611,2311,243-0.72%146,000517億4907万+3.93%
10/091,2551,2581,2251,252+0.64%203,700521億2376万+4.86%
10/081,2601,2741,2371,244-2.35%148,800517億9070万+4.54%
10/071,2511,2861,2461,274+2.82%313,900530億3967万+7.24%
10/041,2381,2471,2271,239-0.48%160,100515億8254万+4.47%
10/031,2451,2541,2301,245+1.88%206,000518億3233万+4.97%
10/021,2101,2331,2041,222-0.16%178,900508億7479万+3.21%
10/011,1731,2251,1701,224+5.06%243,600509億5805万+3.38%
09/301,1801,1941,1621,165-3.48%186,300485億174万-1.44%
09/271,2061,2171,2011,207-1.23%173,100502億5030万+2.12%
09/261,2161,2221,1951,222+0.74%236,900508億7479万+3.56%
09/251,2081,2311,2061,213-0.98%326,300505億10万+3.06%
09/2411:30 株式会社新日本科学とSBIホールディングス株式会社による共同ファンド設立に関するお知らせ
09/241,2311,2451,2191,225+0.57%332,700509億9969万+4.26%
09/201,1971,2301,1871,218+2.96%345,500507億826万+3.92%
09/191,1751,1971,1751,183+1.55%115,800492億5112万+1.46%
09/181,1681,1771,1571,165+1.3%145,400485億174万+0.34%
09/171,1531,1551,1371,150+1.23%163,300478億7726万-0.43%
09/131,1561,1631,1301,136-2.82%270,000472億9440万-1.22%
09/121,1401,1921,1401,169+3.36%327,400486億6827万+1.92%
09/111,1511,1581,1231,131-0.96%316,700470億8624万-0.96%
09/101,1451,1651,1411,142+0.35%208,700475億4420万+0.35%
09/091,1301,1501,1201,138-1.73%223,300473億7767万+0.62%
09/061,1781,1901,1511,158-1.36%195,200482億1031万+2.3%
09/051,1621,2111,1621,174+1.12%362,700488億7643万+3.44%
09/041,1551,1881,1551,161-1.78%245,600483億3521万+2.02%
09/031,1541,1941,1531,182+2.52%226,600492億949万+3.5%
09/021,2041,2081,1461,153-4.55%397,200480億215万+0.79%
08/3013:30 連結子会社の商号変更に関するお知らせ
08/301,2221,2261,2061,208-1.63%972,600502億9193万+5.32%
08/291,2261,2551,2221,228+0.16%185,200511億2458万+7.06%
08/281,2011,2271,1991,226+1.32%143,300510億4132万+6.89%
08/271,2021,2191,1961,210+0.67%114,800503億7520万+5.22%
08/261,1741,2141,1651,202+2.04%212,700500億4214万+4.43%
08/231,1651,1821,1631,178+1.2%125,500490億4296万+2.08%
08/221,1641,1811,1601,1640%150,300484億6011万+0.34%
08/211,1521,1711,1411,164+1.04%211,900484億6011万-0.17%
08/201,1511,1581,1311,1520%352,100479億6052万-1.71%
08/191,1501,1771,1491,152+0.7%346,700479億6052万-2.21%
08/161,1111,1471,1031,144+5.83%444,200476億2746万-3.46%